文献速递妇科产科

子宫托与手术治疗症状性盆腔器官脱垂:PEOPLE 多中心前瞻性队列研究

Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study.
PubMed 文献 · BJOG · 2021-10-28

这项荷兰22家医院的多中心前瞻性比较队列研究纳入539例症状性POP(分期≥2、中重度症状)女性,比较子宫托(335例)与手术(204例)作为初始治疗的24个月疗效。主要结局PGI-I显示手术组主观改善率83.8%,子宫托组74.4%(风险差9.4%,95%CI 1.4-17.3%,P<0.01);两组POP症状困扰和严重程度均较基线显著改善。

要点

  • 手术组24个月主观改善率高于子宫托组(83.8% vs 74.4%,风险差9.4%,95%CI 1.4-17.3%,P<0.01)。
  • 子宫托组23.6%转为手术,手术组10.8%接受额外治疗。
  • 两种治疗均使POP症状困扰与严重程度较基线显著改善(P≤0.01与P≤0.001)。

核心结论

  • 手术组24个月主观改善率显著高于子宫托组,但两种治疗均带来有临床意义的POP症状改善。

研究设计与样本

  • 多中心前瞻性比较队列研究,纳入荷兰22家医院转诊的症状性POP(分期≥2、中重度症状)女性539例,子宫托组335例(62.2%),手术组204例(37.8%)。

主要发现

  • 24个月时手术组134例(83.8%)报告主观改善,子宫托组180例(74.4%)报告主观改善(风险差9.4%,95%CI 1.4-17.3%,P<0.01)。
  • 两组POP相关困扰症状均较基线显著减轻(P≤0.01),自觉症状严重程度亦均较基线显著降低(P≤0.001)。

关键数值与推荐

  • 主要结局为24个月随访时PGI-I量表评估的主观改善。
  • 次要结局包括PFDI-20评估的脱垂相关症状改善、PGI-S评估的主观严重程度改善及治疗交叉情况。
  • 主要安全性结局为不良事件发生。

临床怎么用

  • 对有症状的POP(分期≥2、中重度症状)女性,子宫托与手术均可作为初始治疗选择,两者均能改善症状。
  • 咨询时应告知手术的24个月主观改善概率更高,但子宫托组约四分之一会转为手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the 24-month efficacy of pessary or surgery as the primary treatment for symptomatic pelvic organ prolapse (POP). DESIGN: Multicentre prospective comparative cohort study. SETTING: Twenty-two Dutch hospitals. POPULATION: Women referred with symptomatic POP of stage ≥2 and moderate-to-severe POP symptoms. METHODS: The primary outcome was subjective improvement at the 24-month follow-up according to the Patient Global Impression of Improvement (PGI-I) scale. Secondary outcomes included improvement in prolapse-related symptoms measured with the Pelvic Floor Distress Inventory (PFDI-20), improvement in subjective severeness of symptoms according to the Patient Global Impression of Severity (PGI-S) scale and crossover between therapies. The primary safety outcome was the occurrence of adverse events. MAIN OUTCOME MEASURE: PGI-I at 24 months. RESULTS: We included 539 women, with 335 women (62.2%) in the pessary arm and 204 women (37.8%) in the surgery arm. After 24 months, subjective improvement was reported by 134 women (83.8%) in the surgery group compared with 180 women (74.4%) in the pessary group (risk difference 9.4%, 95% CI 1.4-17.3%, P < 0.01). Seventy-nine women (23.6%) switched from pessary to surgery and 22 women (10.8%) in the surgery group underwent additional treatment. Both groups showed a significant reduction in bothersome POP symptoms (P ≤ 0.01) and a reduction in the perceived severity of symptoms (P ≤ 0.001) compared with the baseline. CONCLUSIONS: Significantly more women in the surgery group reported a subjective improvement after 24 months. Both therapies, however, showed a clinically significant improvement of prolapse symptoms. TWEETABLE ABSTRACT: Pessary treatment and vaginal surgery are both efficacious in reducing the presence and severity of prolapse symptoms, although the chance of significant improvement is higher following surgery.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. van der Vaart LR, Vollebregt A, Milani AL, et al. Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. BJOG. 2021. PMID: 34559932. doi:10.1111/1471-0528.16950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。